At VLX Ventures, we transform visionary ideas into impactful realities. We identify cutting-edge technologies and following an intensive R&D and business validation we establish startups to grow them. This process includes recruiting strong teams, invest in and take a role part in accelerate their growth.Our primary focus is on biopharma therapeutic ventures developing drugs for challenging diseases.

 We also focus on digital pharma ventures that combine deep biology with computational biology to enable efficient, life-saving precision medicine and diagnostics.

We have established companies that push the boundaries of technology and business with the clear goal of saving lives and dramatically improving the quality of life for millions. Our diverse portfolio includes companies at all stages, from early pre-clinical to Phase 3 advanced clinical studies.